BASEL (dpa-AFX) - Novartis (NVS) announced that the US Food and Drug Administration has granted accelerated approval for Vanrafia or atrasentan, a pote...
NeuroSearch Competitors or Alternatives
NeuroSearch's top competitors include ChemDiv, Precision Oncology and NexImmune.
NeuroSearch VS ChemDiv
ChemDiv is the top competitor of NeuroSearch. ChemDiv is a Private company that was founded in San Diego, California in 1991. Like NeuroSearch, ChemDiv also operates in the Medical Research & Laboratories sector. ChemDiv has 414 more employees vs. NeuroSearch.
NeuroSearch VS Precision Oncology
Precision Oncology is seen as one of NeuroSearch's biggest rivals. Precision Oncology was founded in Flemington, New Jersey} in 2000. Like NeuroSearch, Precision Oncology also competes in the Medical Research & Laboratories space. Compared to NeuroSearch, Precision Oncology generates $11.3M less revenue.
NeuroSearch VS NexImmune
NexImmune is perceived as one of NeuroSearch's biggest rivals. NexImmune was founded in 2011, and is headquartered in Gaithersburg, Maryland. Like NeuroSearch, NexImmune also operates in the Pharmaceuticals & Biotechnology space. NexImmune generates $ less revenue vs. NeuroSearch.
Looking for similar companies to NeuroSearch?
Similar Companies
Companies in Hellerup with revenue in $5.0-25M range
See 10 companies
Medical Research & Laboratories companies in EuropeSee 359 companies
Companies in Hellerup with employees in 25-100 rangeSee 13 companies
Pharmaceuticals & Biotechnology companies in DenmarkSee 371 companies
Medical Research & Laboratories companies in EMEASee 374 companies
Medical Research & Laboratories companies with revenue in $5.0-25M rangeSee 528 companies
Medical Research & Laboratories companies with employees in 25-100 rangeSee 569 companies
Companies in Denmark with revenue in $5.0-25M rangeSee 1,060 companies
Companies in Denmark with employees in 25-100 rangeSee 1,350 companies
Trending News for NeuroSearch and NeuroSearch's Competitors
SAN DIEGO, April 02, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing ...
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores....
HOUSTON, April 01, 2025 (GLOBE NEWSWIRE) -- MARKER THERAPEUTICS, INC. (NASDAQ:MRKR), a clinical-stage immuno-oncology company focusing on developing ne...
High-yielding dividend stocks can be great investments to hold on to in your portfolio, but only if they're safe. Betting on a high yield can be danger...
FDA grants accelerated approval to Novartis' Vanrafia for IgA nephropathy, with Phase 3 data in 2026 expected to support traditional approval. read mor...
The authorisation approximately triples the number of patients eligible to receive the therapy...
Positive CHMP opinion for Opdivo subcutaneous formulation across multiple solid tumor indications....
A federal appeals court on Tuesday affirmed the dismissal of a dental surgeon's suit alleging Bristol-Myers Squibb Co.'s leukemia drug Sprycel caused r...
Novartis AG's plan to sell its 70.68% stake in Novartis India faces challenges due to market volatility impacting valuation. Despite strategic reviews ...
Frequently Asked Questions about NeuroSearch
Who are NeuroSearch's top competitors?
NeuroSearch's top 3 competitors are ChemDiv, Precision Oncology, NexImmune.Who is similar to NeuroSearch?
ChemDiv is the most similar to NeuroSearch. Precision Oncology and NexImmune are also similar to NeuroSearch.
Are NeuroSearch and ChemDiv competitors?
Yes, ChemDiv is one of NeuroSearch’s top competitors.